These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8092152)

  • 21. Intravenous admixture incompatibility information program.
    Donn R
    Bull Parenter Drug Assoc; 1970; 24(2):98-103. PubMed ID: 5439919
    [No Abstract]   [Full Text] [Related]  

  • 22. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 23. The bulk compounding of technology of liquids and semi-solids.
    Schumacher GE
    Am J Hosp Pharm; 1969 Feb; 26(2):70-99. PubMed ID: 5766229
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemistry and safety of phosphates injections.
    Newton DW; Driscoll DF
    Am J Health Syst Pharm; 2008 Sep; 65(18):1761-6. PubMed ID: 18769005
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology.
    Driscoll DF; Bistrian BR; Demmelmair H; Koletzko B
    Clin Nutr; 2008 Aug; 27(4):497-503. PubMed ID: 18582994
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 27. R: calcium, phosphate, and Secundum artem.
    Newton DW
    Nutrition; 1997 Apr; 13(4):390-1. PubMed ID: 9178300
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress in galenicals (1962-1964)].
    Chalabala M; Malý J; Zácek H
    Pharmazie; 1966 Feb; 21(2):73-95. PubMed ID: 4861050
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemical and physical bases determining the instability and incompatibility of formulated injectable drugs.
    Stella VJ
    J Parenter Sci Technol; 1986; 40(4):142-63. PubMed ID: 3534205
    [No Abstract]   [Full Text] [Related]  

  • 31. Incompatibility of drugs for intravenous administration.
    Med Lett Drugs Ther; 1967 Aug; 9(17):67-8. PubMed ID: 6050661
    [No Abstract]   [Full Text] [Related]  

  • 32. The development of fat emulsions.
    MacFie J
    Nutrition; 1999; 15(7-8):641, 643-5. PubMed ID: 10422103
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of fat emulsions. 1981.
    Wretlind A
    Nutrition; 1999; 15(7-8):642. PubMed ID: 10532796
    [No Abstract]   [Full Text] [Related]  

  • 34. Maximizing calcium and phosphate content in neonatal parenteral nutrition solutions using organic calcium and phosphate salts.
    Bouchoud L; Fonzo-Christe C; Sadeghipour F; Bonnabry P
    JPEN J Parenter Enteral Nutr; 2010; 34(5):542-5. PubMed ID: 20852183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous admixture incompatibility.
    Donn R
    Am J Nurs; 1971 Feb; 71(2):325. PubMed ID: 5203610
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous solution manual and incompatibility file; its use in a community hospital.
    Donn R
    Am J Hosp Pharm; 1967 Aug; 24(8):459-61. PubMed ID: 6075731
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in the coalescence kinetics of fat emulsions in dependence on the amount of fat and age.
    Harnisch S; Schuhmann R; Harnisch JF; Müller RH
    Pharmazie; 2002 Jan; 57(1):54-8. PubMed ID: 11836933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why are aqueous suspensions of the coarse grades of anhydrous calcium hydrogen phosphate acidic?
    Eyjolfsson R
    Pharmazie; 2010 Jul; 65(7):527. PubMed ID: 20662325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Galenic considerations concerning a new cream preparation].
    Nürnberg E
    Arzneimittelforschung; 1966 Jan; 16(1):14-8. PubMed ID: 6013750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incompatibility of drugs designed for intravascular use].
    Berglund A; Kolmodin CG; Hamfelt A; Lundgren A
    Lakartidningen; 1966 Jan; 63(4):296-7. PubMed ID: 5913320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.